DUBLIN, May 27, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Continuous Renal Replacement Therapy (CRRT) Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Continuous Renal Replacement Therapy (CRRT) Market is poised to grow at a CAGR of around 8.3% over the next decade to reach approximately $1.6 billion by 2025.
This industry report analyzes the global markets for Continuous Renal Replacement Therapy (CRRT) across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 The clinical advantages in CRRT Techniquesis are favoring the market growth
3.1.2 Rapid growth in aging population and increased prevalence of sepsis are the key factors responsible for the rise in demand
3.1.3 Recent Technological Developments of Continuous Renal Replacement Therapy
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Continuous Renal Replacement Therapy (CRRT) Market, By Modality
4.1 Slow-Continuous Ultrafiltration (SCUF)
4.2 Continuous Venovenous Hemodialysis (CVVHD)
4.2.1.1 Continuous arteriovenous hemodialysis (CAVHD)
4.3 Continuous Venovenous Hemofiltration (CVVH)
4.3.1.1 Continuous arteriovenous hemofiltration (CAVVHF)
4.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
5 Continuous Renal Replacement Therapy (CRRT) Market, By Product
5.1 CRRT Systems
5.2 Replacement Fluids
5.3 CRRT Disposables
5.3.1.1 Bloodline Sets
5.3.1.2 Hemofilters
5.3.1.3 Blood purification equipments
5.3.1.4 Other Disposables
5.4 Dialysate
5.5 CRRT concentrates
5.6 CRRT Solutions
6 Continuous Renal Replacement Therapy (CRRT) Market, By Geography
7 Leading Companies
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Baxter International Inc.
- Bellco S.R.L
- Covidien Ltd.
- Diaverum
- Fresenius Medical Care AG & Co. KGAA
- Gambro AB
- Infomed SA
- Medica S.P.A
- Medical Components, Inc.
- Medites Pharma spol. S R.o.
- Nikkiso Co., Ltd
- Nxstage Medical, Inc.
- Terumo BCT
- Toray Medical Company Limited
For more information visit http://www.researchandmarkets.com/research/22h6bl/global_continuous
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article